AB
SLS icon

Amalgamated Bank’s SELLAS Life Sciences SLS Stock Holding History

Amalgamated Bank’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,892
Closed -$15K – 2638
2025
Q4 		$15K Buy
3,892
+633
+19% +$1.23K ﹤0.01% 2254
2025
Q3 		$5K Hold
3,259
– – ﹤0.01% 2794
2025
Q2 		$7K Buy
+3,259
New +$5K ﹤0.01% 2604

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Amalgamated Bank's SLS Position: Q1 2026 in Review

Amalgamated Bank sold out of SELLAS Life Sciences (SLS) in Q1 2026, closing a stake of 3,892 shares — an estimated $15K sold.

Amalgamated Bank first reported a position in SLS in Q2 2025 and held it in 3 quarters. The position peaked at $15K in Q4 2025. 160 funds tracked by Wall St. Rank hold SLS as of Q1 2026.

  • Amalgamated Bank reported no remaining SELLAS Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 3,892 SELLAS Life Sciences shares in Q1 2026, an estimated $15K.
  • Amalgamated Bank first reported a position in SELLAS Life Sciences in Q2 2025 and held it in 3 quarters.
  • Amalgamated Bank's SELLAS Life Sciences position peaked at $15K in Q4 2025.
  • 160 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.